Ticagrelor monotherapy beyond 1 month versus standard dual antiplatelet therapy after drug-eluting coronary stenting: a pre-specified per-protocol analysis of the GLOBAL LEADERS trial
Felice Gragnano, Marcel Zwahlen, P Vranckx, Peter Jüni, Dik Heg, Christian W. Hamm, Philippe Gabríel Steg, Niels Hagenbuch, Giuseppe Gargiulo, Robert‐Jan van Geuns, Kurt Huber, Ronald van Amsterdam, Patrick W. Serruys, Marco Valgimigli, Stephan Windecker (2020). Ticagrelor monotherapy beyond 1 month versus standard dual antiplatelet therapy after drug-eluting coronary stenting: a pre-specified per-protocol analysis of the GLOBAL LEADERS trial. European Heart Journal, 41(Supplement_2), DOI: 10.1093/ehjci/ehaa946.2577.
